XML 13 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Condensed Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2017
Dec. 31, 2016
Current Assets:    
Cash and cash equivalents $ 133,907 $ 177,187
Accounts receivable, less allowance of $1,344 and $1,391, respectively 185,279 170,084
Inventory:    
Raw materials 59,425 60,525
Work in process 17,070 13,261
Finished goods 31,960 31,288
Inventory, net 108,455 105,074
Derivative financial instruments 1,594 18
Prepaid expenses and other assets 43,868 36,390
Total current assets 473,103 488,753
Property and equipment, net 179,848 172,052
Goodwill 52,031 51,735
Other intangible assets, net 55,219 57,557
Deferred financing costs 1,149 1,221
Deferred income tax assets 35,931 35,299
Other non-current assets 35,397 36,413
Total assets 832,678 843,030
Current Liabilities:    
Accounts payable 86,156 84,511
Accrued liabilities 64,896 105,625
Current maturities of long-term debt 2,105 2,092
Derivative financial instruments   1,395
Total current liabilities 153,157 193,623
Pension benefit obligation 7,571 7,419
Other liabilities 5,115 4,092
Long-term debt, less current maturities 161,032 169,433
Deferred income tax liabilities 8,544 8,058
Total liabilities 335,419 382,625
Common Stock:    
No par value; 55,000,000 shares authorized, 36,727,501 and 36,534,464 issued and outstanding at March 31, 2017 and December 31, 2016, respectively 263,656 262,251
Paid-in capital 11,176 10,323
Accumulated other comprehensive loss (61,393) (69,091)
Accumulated earnings 283,820 256,922
Total shareholders’ equity 497,259 460,405
Total liabilities and shareholders’ equity $ 832,678 $ 843,030